[HTML][HTML] Pneumococcal disease: a systematic review of health utilities, resource use, costs, and economic evaluations of interventions
Background Pneumococcal diseases cause substantial mortality, morbidity, and economic
burden. Evidence on data inputs for economic evaluations of interventions targeting …
burden. Evidence on data inputs for economic evaluations of interventions targeting …
The societal value of universal childhood vaccination
I Chabot, MM Goetghebeur, JP Grégoire - Vaccine, 2004 - Elsevier
Availability of new vaccines preventing infectious diseases in healthy children populations is
increasing worldwide. In Canada, despite the current recommendation of the National …
increasing worldwide. In Canada, despite the current recommendation of the National …
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
Background The 7-valent pneumococcal conjugate vaccine has been introduced in national
immunisation programmes of most industrialised countries and recently in two African GAVI …
immunisation programmes of most industrialised countries and recently in two African GAVI …
The burden of acute otitis media on the patient and the family
D Greenberg, N Bilenko, Z Liss, T Shagan… - European journal of …, 2003 - Springer
The aim of our study was to determine the burden of acute otitis media (AOM) on patients
and their families. Parents of children with AOM were interviewed with regard to the week …
and their families. Parents of children with AOM were interviewed with regard to the week …
Community-acquired pneumonia in children: quantifying the burden on patients and their families including decrease in quality of life
Objectives. Childhood respiratory infections have an important impact on society and are a
frequent cause of physician visits, consumption of antibiotics and over-the-counter drugs …
frequent cause of physician visits, consumption of antibiotics and over-the-counter drugs …
The cost-effectiveness of pneumococcal conjugate vaccination in Australia
Background: Pneumococcal conjugate vaccine, 7 valent (PCV7) is the most costly vaccine
yet considered for publicly funded programs. In mid 2001, Australia funded PCV7 for high …
yet considered for publicly funded programs. In mid 2001, Australia funded PCV7 for high …
Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects
C Claes, RR Reinert… - The European Journal of …, 2009 - Springer
Abstract Background In Germany the heptavalent pneumococcal conjugate vaccine (PCV7)
has been recommended as a general infant vaccination since 2006. Data from similar …
has been recommended as a general infant vaccination since 2006. Data from similar …
Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines
OBJECTIVE: To review the approaches used in the cost-effectiveness analysis (CEAs)
literature to estimate the cost of expanded program on immunization (EPI) activities, other …
literature to estimate the cost of expanded program on immunization (EPI) activities, other …
Cost-effectiveness of universal pneumococcal vaccination for infants in Italy
This study aimed at estimating the health and economic outcomes of universal infant
vaccination with seven-valent pneumococcal conjugate vaccine (PCV-7) in Italy. A Markov …
vaccination with seven-valent pneumococcal conjugate vaccine (PCV-7) in Italy. A Markov …
Economic aspects of pneumococcal pneumonia: a review of the literature
In this review, the economic aspects of pneumococcal pneumonia are analysed, including
the costs, cost effectiveness and cost benefit of treatment and prevention. We identified eight …
the costs, cost effectiveness and cost benefit of treatment and prevention. We identified eight …